524711 — Vista Pharmaceuticals Share Price
0.000.00%
Last trade - 00:00- IN₹624.22m
- IN₹714.36m
- IN₹10.04m
- 25
- 12
- 45
- 12
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.62 | ||
| Price to Tang. Book | 2.15 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 7.65 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -19.41% | ||
| Return on Equity | -23.21% | ||
| Operating Margin | -101.59% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 310.73 | 227.59 | 12.66 | 3.95 | 10.04 | n/a | n/a | -48.94% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -58.37 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Vista Pharmaceuticals Limited is an India-based company that is engaged in manufacturing and selling of pharmaceutical, medical, and veterinary preparations. The Company also sells the products to its related companies, which are engaged in the manufacture of formulations. It offers over the counter and prescription generic drug products, consisting of tablets, capsules and liquids covering various therapeutic categories. Its products include tablet dosage forms in the United States market, such as Sulfamethoxazole & Trimethoprim, Acetaminophen, Bismuth Subsalicylate, Bismuth Subgallate, Ferrous Gluconate, Ferrous Sulfate, Pyrantel Pamoate and Isoxsuprine HCl and tablet dosage forms in the non-United States market, such as Aspirin, Atenolol, Mebendazole, Nefidipine, Quinine Sulfate, Ranitidine HCl, Magnesium Trisilicate Compound, Aluminium Hydroxide, Folic Acid and Captopril. Its capsule dosage forms in the non-United States market include Indomethacin, Piroxicam and Nefidipine.
Directors
- Suneel Pachipala CFO
- Aakash Bhagadia CCO
- Dhananjaya Alli MDR
- Adduri Lakshmi SEC
- Stanely Reddy DRC
- M. Rao NED
- Divakar Yerrabommanahalli NED
- Chittajallu Anand NID
- Umesh Banakar NID
- Chakravarthula Bhavani NID
- Narendra Gilaka NID
- Vani Vatti NID
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 25th, 1991
- Public Since
- July 21st, 2003
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 46,898,232
- Address
- 7-1-212/A/70, HYDERABAD, 500081
- Web
- http://vistapharmaceuticals.com/
- Phone
- +91 4023738872
- Auditors
- A. M. Reddy & Co
Upcoming Events for 524711
Q1 2025 Vista Pharmaceuticals Ltd Earnings Release
Vista Pharmaceuticals Ltd Annual Shareholders Meeting
Similar to 524711
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
Ambalal Sarabhai Enterprises
Bombay Stock Exchange
FAQ
What is the Vista Pharmaceuticals share price?
As of Today at 19:24 UTC, shares in Vista Pharmaceuticals are trading at IN₹13.31. This share price information is delayed by 15 minutes.
How has the Vista Pharmaceuticals share price performed this year?
Shares in Vista Pharmaceuticals last closed at IN₹13.31 and the price had moved by +34.31% over the past 365 days. In terms of relative price strength the Vista Pharmaceuticals share price has outperformed the S&P BSE 100 Index by +4.17% over the past year.
What are the analyst and broker recommendations for Vista Pharmaceuticals?
There is no consensus recommendation for this security.
What is the Vista Pharmaceuticals dividend yield?
Vista Pharmaceuticals does not currently pay a dividend.
Does Vista Pharmaceuticals pay a dividend?
Vista Pharmaceuticals does not currently pay a dividend.
When does Vista Pharmaceuticals next pay dividends?
Vista Pharmaceuticals does not currently pay a dividend.
How do I buy Vista Pharmaceuticals shares?
To buy shares in Vista Pharmaceuticals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Vista Pharmaceuticals?
As of the previous close price of IN₹13.31, shares in Vista Pharmaceuticals had a market capitalisation of IN₹624.22m.
Where are Vista Pharmaceuticals shares listed?
Here are the trading details for Vista Pharmaceuticals:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 524711
What kind of share is Vista Pharmaceuticals?
Based on an overall assessment of its quality, value and momentum Vista Pharmaceuticals is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Vista Pharmaceuticals share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Vista Pharmaceuticals share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vista Pharmaceuticals. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -32.5%.
As of the last closing price of IN₹13.31, shares in Vista Pharmaceuticals were trading -8.61% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Vista Pharmaceuticals PE Ratio?
The Vista Pharmaceuticals PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹13.31.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Vista Pharmaceuticals?
Vista Pharmaceuticals' management team is headed by:
- Suneel Pachipala - CFO
- Aakash Bhagadia - CCO
- Dhananjaya Alli - MDR
- Adduri Lakshmi - SEC
- Stanely Reddy - DRC
- M. Rao - NED
- Divakar Yerrabommanahalli - NED
- Chittajallu Anand - NID
- Umesh Banakar - NID
- Chakravarthula Bhavani - NID
- Narendra Gilaka - NID
- Vani Vatti - NID